Fact sheet: AXA Framlington Health

Fund information
Fund name
AXA Framlington Health Z Inc
Fund manager company
AXA IM UK
Fund type
Unit Trust
Fund managers
  • Dani Saurympersince 31/03/2015
Fund objective
Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies
Benchmark
  • MSCI World Healthcare
Investment style
Growth
Investment method
Shares
Quick stats
1 Year return
5.3%
1 Year rank in sector
84/123
Sector
UT Specialist
Yield
0.4%
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
0.83%
Fund size
£510m (£517m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
138
Top in this sector
Fund name1 Year
MFM Junior Gold123.8%
WAY Charteris Gd Prcsml109%
CF Ruffer Gold81.7%
Smith & Williamson GblGld&Res79.1%
Investec Global Gold74%
...more in UT Specialist

Performance snapshot

Holdings snapshot

  • North America69.2%
    Europe ex UK13.2%
    UK9.4%
    Money Market3.6%
    Japan3.3%
  • Biotechnology/Medical30.4%
    Pharmaceuticals27.4%
    Health Care17.7%
    Healthcare & Medical Products16.6%
    Money Market3.6%
  • North American Equities69.2%
    Europe ex UK Equities13.2%
    UK Equities9.4%
    Money Market3.6%
    Japanese Equities3.3%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund-3.3%-4.8%4.7%5.3%50.7%129.7%
Sector-3.5%-0.5%10%16%14.1%25.5%
Rank within sector83 / 124107 / 12584 / 12584 / 1237 / 1143 / 91
Quartile3rd4th3rd3rd1st1st
Calendar performance
 YTD - 20162015201420132012
Fund2.6%12.2%29.6%34.6%11.2%
Sector18%-4.5%1.2%4.5%7.5%
Rank within sector103 / 1245 / 1195 / 1152 / 10543 / 91
Quartile4th1st1st1st2nd
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
12.17
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.75
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.84
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
14.79
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
13.02
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.75
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.25
Price movement
52 week high123.9
52 week low91.83
Current bid price-
Current offer price-
Current mid price108.7
Region
1North America69.24%
2Europe ex UK13.22%
3UK9.44%
4Money Market3.55%
5Japan3.26%
6Global Emerging Markets1.29%
Industry sector
1Biotechnology/Medical30.41%
2Pharmaceuticals27.35%
3Health Care17.68%
4Healthcare & Medical Products16.59%
5Money Market3.55%
6Hospital1.84%
7Food & Drug Retailers1.55%
8Conglomerates1.03%
Asset type
1North American Equities69.24%
2Europe ex UK Equities13.22%
3UK Equities9.44%
4Money Market3.55%
5Japanese Equities3.26%
6Global Emerging Market Equities1.29%
Individual holdings
1ROCHE HLDG AG5%
2GLAXOSMITHKLINE PLC4.6%
3ALLERGAN PLC4.2%
4GILEAD SCIENCES INC4.2%
5UNITEDHEALTH GROUP INC4.2%
6CELGENE CORP4%
7MEDTRONIC INC3.7%
8LILLY (ELI) & CO3.5%
9ABBVIE INC3.3%
Management
Fund manager group
AXA Investment Managers
Fund manager company
AXA IM UK
Fund type
Unit Trust
Fund objective
Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies
Benchmark
  • MSCI World Healthcare
Investment style
Growth
Investment method
Shares
Fund managers
NameSinceBiography
Dani Saurymper31/03/2015Dani Saurymper joined AXA IM in April 2015 as Portfolio Manager for the AXA Framlington Health funds. Dani has 14 years’ experience. Prior to joining AXA IM in April 2015 as Portfolio Manager, he was a senior equity research analyst covering European Healthcare at Barclays Capital. Dani started his career at Goldman Sachs as a senior pharmaceutical analyst covering European Pharmaceuticals, before moving to Nomura as a sector specialist covering global healthcare Dani graduated from Leeds University with a BSc in Management Studies and Pharmacology and holds an MSc in International Business from the Manchester School of Management, UMIST.
Compliance
Transparent for Swiss Tax, IA Recognised, UCITS IV Compliant, UCITS V Compliant
Domicile
No data available.
Fund for sale in
Switzerland, United Kingdom
AXA Framlington Health R Acc
Initial charge5.5%
Annual charge1.5%
Min single investment£1,000
Min regular saving£100
Available in ISAYes
Ongoing charge (OCF)1.58%
Total expense ratio (TER)1.58%
Bid price-
Offer price-
Mid price1667
CurrencyGBX
Price updated02/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeFR45
AXA Framlington Health R Inc
Initial charge5.5%
Annual charge1.5%
Min single investment£1,000
Min regular saving£100
Available in ISAYes
Ongoing charge (OCF)1.58%
Total expense ratio (TER)1.58%
Bid price-
Offer price-
Mid price1667
CurrencyGBX
Price updated02/12/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeFR44
AXA Framlington Health Z Acc
Initial charge-
Annual charge0.75%
Min single investment£100,000
Min regular saving£5,000
Available in ISANo
Ongoing charge (OCF)0.83%
Total expense ratio (TER)0.85%
Bid price-
Offer price-
Mid price216.9
CurrencyGBX
Price updated02/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi code11VI
AXA Framlington Health Z Inc
Initial charge-
Annual charge0.75%
Min single investment£100,000
Min regular saving£5,000
Available in ISANo
Ongoing charge (OCF)0.83%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price108.7
CurrencyGBX
Price updated02/12/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeM4KM
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.